TDP2 and lung carcinoma: Although TDP2-defective cancer cells will be hypersensitive to this type of chemotherapy, normal cells will also be hypersensitive, as illustrated in the current work by the etoposide sensitivity observed in both TDP2−/− A549 lung cancer cells and SCAR23 primary fibroblasts.